glp-1 diabetes Targeting GLP-1, GIP & GCG in Obesity and Type 2 Research – Caltag Medsystems Targeting GLP-1, GIP & GCG
Description
A trusted treatment to support long-term health, balance, and wellness.
META Multi helps fill common nutrient gaps associated with GLP-1 use
Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia
Clinically-Studied Ingredients
Prescription product
Over 30 million Americans are using medications like Wegovy and Ozempic, but surgeons say rapid muscle loss is causing an unexpected side effect: back pain.
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
